Analysis

Part D's $700 Deductible Meets the DPC Dispensary in 2027

KFF projects stand-alone Part D premiums rising from $34 to $51 a month in 2027 for enrollees who keep their plans, with no $0 plans left. For Medicare patients who buy generics at a DPC practice's dispensary, the rules on what counts toward the deductible matter more than they did.

Research Desk 5 min read Analysis

A small amber pharmacy vial on a dark counter beside an empty wire coin tray, lit from behind by a rose-pink glow.

About 4.1 million people in stand-alone Medicare drug plans paid no monthly premium in 2026 and will pay one in 2027, because KFF found no $0-premium stand-alone plans available next year for enrollees without the Part D low-income subsidy, known as Extra Help. KFF’s Oct. 30 analysis projects the average stand-alone premium rising from $34 a month to $51 for people who keep their current plan, and it sets the standard deductible at $700, up from $615.

Those numbers raise a narrower question for one group of patients. These are Medicare patients whose doctor runs a direct primary care practice and sells generic drugs at the front desk.

The 2027 numbers, and how firm they are

KFF’s figures rest on June 2026 enrollment and assume nobody switches plans. That assumption is the main caveat, and KFF states it. CMS projected a national average premium of $36, up $1 from $35, and KFF says CMS did not explain its method. The estimate at the start of last year’s open enrollment was $44 for 2026, and the actual average came in at $34 after people changed plans. KFF expects the real 2027 figure to land below $51 for the same reason.

The deductible numbers are firmer, because they describe plan designs already filed:

  • Virtually all stand-alone plan enrollees, 99.8%, are in plans that charge a deductible in 2027, up from 96%.
  • The average stand-alone plan deductible rises from $540 to $643.
  • Among Medicare Advantage drug plan enrollees, 85% face a deductible, and the average rises from $360 to $489.

Medicare.gov describes the deductible stage plainly: if your plan has one, you pay all out-of-pocket costs until you reach it. After that, enrollees pay 25% coinsurance until their out-of-pocket spending on covered Part D drugs reaches $2,400 in 2027, up from $2,100 this year.

Where DPC practices come in

Most DPC physicians are outside Medicare’s billing system. The DPC Alliance’s 2026 State of Direct Primary Care report surveyed 465 physicians and found 80.7% had opted out of Medicare entirely. Another 15.5% had opted in but do not see Medicare patients, and 3.9% bill Medicare.

In-office dispensing was part of the DPC pitch to the Senate in 2019. Josh Umbehr, M.D., co-founder of AtlasMD Family Practice in Wichita, told the Senate HELP Committee that direct primary care can offer “discounts up to 95% on [wholesale] medications and labs.” He also told the committee that “44 states make it very easy for physicians to dispense medications.” Those are his claims, made as an advocate for the model, and prices vary by practice. Physician dispensing regulations vary by state, and physicians are responsible for verifying their state’s requirements. DPC Frontier tracks the differences.

Put the two together and you get a patient who pays a Part D premium that may have just gone from $0 to something, faces a deductible near $700, and may be able to buy generics at their doctor’s office. Whether the cash price beats the plan depends on the drug and the plan. KFF puts median standard cost sharing in stand-alone plans at a $4 copay for preferred generics and $20 for other generics.

The question patients will bring to the exam room

The first version of the question is whether to keep a drug plan at all. Medicare.gov answers that one directly. You may owe a late enrollment penalty if, after your initial enrollment period, you go 63 or more days in a row without Medicare drug coverage or other creditable coverage, and you’ll generally pay that penalty for as long as you have Medicare drug coverage. The same page tells people who take few drugs to “consider getting a drug plan with a low monthly premium so you can avoid the late enrollment penalty.” KFF’s analysis shows that low-premium plans still exist. The two cheapest national plans it lists average $6.50 and $10.90 a month in 2027.

The second version is harder. When a member buys a generic at the practice instead of filling it through their plan, does that spending count toward the $700 deductible or the $2,400 cap?

Medicare.gov’s page on drug costs addresses the nearest case. It says TrumpRx and other discount cards aren’t creditable coverage, and that when you use them instead of your Medicare plan, the purchase “doesn’t count toward your Medicare deductible or out-of-pocket maximum.” If a dispensary sale is treated the same way, a patient who takes only cheap generics loses little, since a few dollars a month adds up to far less than $700 over a year. A patient who also takes a costly brand drug through the plan is in a different spot. Their cash generic purchases would move them no closer to the deductible or the cap.

For that second patient, Medicare.gov points to the Medicare Prescription Payment Plan, which spreads out-of-pocket costs for drugs covered by the plan across the calendar year. Open enrollment for 2027 coverage runs Oct. 15 to Dec. 7, according to Medicare.gov.

The open question

None of the sources here says how a purchase from a physician’s in-office dispensary is treated for Part D. Medicare.gov’s rule names discount cards. KFF’s analysis covers plan premiums and cost sharing, and doesn’t address drugs bought outside a plan. The DPC Alliance survey reports Medicare status, not how many members on Medicare buy drugs at the practice or what they spend there. A practice that wants to give a Medicare member a straight answer has to get it from the member’s own plan, whose explanation of benefits shows what counted toward out-of-pocket costs. Medicare.gov says that statement lists the prescriptions filled and what counted toward the patient’s costs.

Sources

You might also like

The DPC news that matters, in 5 minutes.

DPC Insider breaks down direct primary care news, policy, and research so you can see what changed and why it matters.